UPITTi002-A-1

Registration Summary:

A P E C

PLN-R9C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	UPITTi002-A-1
Cite as:	UPITTi002-A-1 (RRID:CVCL_C0EU)
Alternative name(s)	PLN-R9C
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	17th July 2021
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	University of Pittsburgh (UPITT)
External Databases
Cellosaurus	CVCL_C0EU
Wikidata	Q112930525
General Information
Publications	Barndt RJ et al. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing. Stem cell research. 2021 Oct;56:102544. Dong M et al. CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases. Pharmacological research. 2022 Nov;185:106480. Barndt RJ et al. Metabolic Maturation Exaggerates Abnormal Calcium Handling in a Lamp2 Knockout Human Pluripotent Stem Cell-Derived Cardiomyocyte Model of Danon Disease. Biomolecules. 2022 Dec 29;13(1). Nandy Krittika et al. Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression. Scientific Reports. 2023-12-11. Munshi Ingita Dey et al. Recent development in CRISPR-Cas systems for cardiac disease. Progress in Molecular Biology and Translational Science. 2024-00-00.
Subclone of	UPITTi002-A

hIPSC Derivation

General
The source cell information can be found in the parental cell line UPITTi002-A.